Details

Edit Details Section
  • Company Type For Profit
EvolutionaryScale is a developer of biological artificial intelligence models for therapeutic design. The business predicts protein structures by combining biological data from DNA sequences, gene expression, and epigenetic states, allowing scientists to use massive language models to create RNA-based medicinal therapies.

Lists Featuring This Company

Edit Lists Featuring This Company Section
United States Startups (Top 10K)
9,780 Number of Organizations • $648.4B Total Funding Amount • 90,957 Number of Investors
Health Care Seed Stage Companies With Fewer Than 100 Employees (Top 10K)
9,995 Number of Organizations • $16.1B Total Funding Amount • 22,483 Number of Investors
East Coast Seed Stage Companies (Top 10K)
9,972 Number of Organizations • $34.9B Total Funding Amount • 27,625 Number of Investors
City of New York Health Care Companies
4,570 Number of Organizations • $115.4B Total Funding Amount • 5,698 Number of Investors

Frequently Asked Questions

Edit Frequently Asked Questions Section
Where is EvolutionaryScale's headquarters? EvolutionaryScale is located in New York, New York, United States.Who invested in EvolutionaryScale? EvolutionaryScale has 5 investors including NVentures and Daniel Gross.How much funding has EvolutionaryScale raised to date? EvolutionaryScale has raised
$142M
.When was the last funding round for EvolutionaryScale? EvolutionaryScale closed its last funding round on Jun 25, 2024 from a Seed round.Who are EvolutionaryScale's competitors? Alternatives and possible competitors to EvolutionaryScale may include Eikon Therapeutics, Interius BioTherapeutics, and Vivodyne.